Cargando…

Author Correction: PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma

Detalles Bibliográficos
Autores principales:	Yokoyama, Daiju, Hisamori, Shigeo, Deguchi, Yasunori, Nishigori, Tatsuto, Okabe, Hiroshi, Kanaya, Seiichiro, Manaka, Dai, Kadokawa, Yoshio, Hata, Hiroaki, Minamiguchi, Sachiko, Tsunoda, Shigeru, Obama, Kazutaka, Sakai, Yoshiharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536706/ https://www.ncbi.nlm.nih.gov/pubmed/34686762 http://dx.doi.org/10.1038/s41598-021-00915-1

Ejemplares similares

PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
por: Yokoyama, Daiju, et al.
Publicado: (2021)

Robotic gastric mobilization in robotic minimally invasive esophagectomy
por: Tsunoda, Shigeru, et al.
Publicado: (2020)

The Incidence of Postoperative Complications after Gastrectomy Increases in Proportion to the Amount of Preoperative Visceral Fat
por: Okada, Kazuyuki, et al.
Publicado: (2019)

Killian-Jamieson diverticulum safely resected using a manual intraoperative neural monitoring system: a case report
por: Ataka, Ryo, et al.
Publicado: (2020)

McKeown esophagectomy with concomitant median arcuate ligament release in a case of esophageal cancer with celiac artery stenosis
por: Hanada, Keita, et al.
Publicado: (2022)

Comparative Outcomes of Laparoscopic Gastrectomy and Open Gastrectomy for Scirrhous Gastric Cancer: A Multicenter Retrospective Cohort Study
por: Fujita, Yusuke, et al.
Publicado: (2021)

Three-dimensional Stereoscopic Visualization Shortens Operative Time in Laparoscopic Gastrectomy for Gastric Cancer
por: Itatani, Yoshiro, et al.
Publicado: (2019)

Iatrogenic diaphragmatic hernia as a late complication of laparoscopic excisional biopsy of peritoneal nodules: A case report
por: Hashimoto, Kyoichi, et al.
Publicado: (2020)

A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus
por: Hanada, Keita, et al.
Publicado: (2022)

Laparoscopic resection of idiopathic jejunal arteriovenous malformation after metallic coil embolization
por: So, Makiko, et al.
Publicado: (2018)

MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients with Stage II/III Colorectal Cancer
por: Nishiuchi, Aya, et al.
Publicado: (2019)

F-Box/WD Repeat Domain-Containing 7 Induces Chemotherapy Resistance in Colorectal Cancer Stem Cells
por: Honma, Shusaku, et al.
Publicado: (2019)

Laparoscopic distal gastrectomy for gastric cancer patient with intestinal malrotation: report of a case
por: Inamoto, Susumu, et al.
Publicado: (2019)

Prevalence and safety of robotic surgery for gastrointestinal malignant tumors in Japan
por: Nishigori, Tatsuto, et al.
Publicado: (2022)

A Randomized Phase II Study of S-1 Adjuvant Chemotherapy With or Without Hochu-ekki-to, a Japanese Herbal Medicine, for Stage II/III Gastric Cancer: The KUGC07 (SHOT) Trial
por: Okabe, Hiroshi, et al.
Publicado: (2019)

Identification of complications requiring interventions after gastrointestinal cancer surgery from real‐world data: An external validation study
por: Kinoshita, Hiromitsu, et al.
Publicado: (2023)

Laparoscopy endoscopy cooperative surgery for gastric plexiform fibromyxoma: a case report
por: Inoue, Yoshikage, et al.
Publicado: (2016)

Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
por: Davidson, Michael, et al.
Publicado: (2016)

Safe implementation of robotic gastrectomy for gastric cancer under the requirements for universal health insurance coverage: a retrospective cohort study using a nationwide registry database in Japan
por: Suda, Koichi, et al.
Publicado: (2021)

Laparoscopic appendectomy for acute appendicitis: How to discourage surgeons using inadequate therapy
por: Hori, Tomohide, et al.
Publicado: (2017)

Direct percutaneous access to a mesenteric vein for antegrade embolization of esophageal varices: A case report
por: Onishi, Yasuyuki, et al.
Publicado: (2021)

Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
por: Cheong, E. Von, et al.
Publicado: (2021)

Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo
por: Kim, Jin-Soo, et al.
Publicado: (2023)

Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer: A Large, Multicenter, Propensity Score Matched Cohort Study in Japan
por: Hida, Koya, et al.
Publicado: (2018)

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
por: Sawaki, Akira, et al.
Publicado: (2011)

A Simple Preparation Method of Gelatin Hydrogels Incorporating Cisplatin for Sustained Release
por: Suzuki, Takahisa, et al.
Publicado: (2022)

Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma
por: Catenacci, D.V.T., et al.
Publicado: (2021)

MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN
por: Ye, Xingming, et al.
Publicado: (2014)

PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2017)

Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
por: Al‐Batran, Salah‐Eddin, et al.
Publicado: (2020)

Emerging Targeted Therapies for HER2 Positive Gastric Cancer That Can Overcome Trastuzumab Resistance
por: Mitani, Seiichiro, et al.
Publicado: (2020)

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer
por: Fujita, T, et al.
Publicado: (2006)

Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer
por: Sun, Lichao, et al.
Publicado: (2016)

PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
por: Kim, Chan, et al.
Publicado: (2017)

External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
por: Jimenez-Fonseca, Paula, et al.
Publicado: (2021)

Nonsurgical Management Following Local Resection for Early Rectal Cancer in Patients with High-risk Factors: A Single-institute Experience
por: Nishizaki, Daisuke, et al.
Publicado: (2020)

Robust Anti-tumor Response in a Patient with Metastatic Gastroesophageal Junction Adenocarcinoma on Long-term Maintenance Chemotherapy With Trastuzumab Alone: An Unusual Occurrence
por: Haider, Salman, et al.
Publicado: (2020)

Real‐world clinical outcomes of the combination of anti‐PD‐1 antibody, trastuzumab, and chemotherapy for HER2‐positive gastric/gastroesophageal junction cancer
por: Yang, Ju, et al.
Publicado: (2023)

Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients
por: Yamamoto, Takehito, et al.
Publicado: (2021)

Colorectal Advanced Neoplasms Occur through Dual Carcinogenesis Pathways in Individuals with Coexisting Serrated Polyps
por: Yamada, Atsushi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tl87569jomltb7tmaboobpp5r2